2001
Family history of cancer and risk of esophageal and gastric cancers in the United States
Dhillon P, Farrow D, Vaughan T, Chow W, Risch H, Gammon M, Mayne S, Stanford J, Schoenberg J, Ahsan H, Dubrow R, West A, Rotterdam H, Blot W, Fraumeni J. Family history of cancer and risk of esophageal and gastric cancers in the United States. International Journal Of Cancer 2001, 93: 148-152. PMID: 11391635, DOI: 10.1002/ijc.1294.Peer-Reviewed Original ResearchConceptsNon-cardia gastric adenocarcinomaFamily historyGastric cancerEsophageal cancerGastric adenocarcinomaEsophageal adenocarcinomaEsophageal squamous cell cancerNon-cardia gastric cancerEsophageal squamous cell carcinomaSquamous cell cancerRisk of esophagealSquamous cell carcinomaCase-control studyGastric cardia adenocarcinomaHigh incidence areaGastric cardiaIncreased riskCell carcinomaDigestive cancersRisk factorsStomach cancerProstate cancerBreast cancerGastric tumorsCardia adenocarcinoma
2000
Oxychlordane and trans-nonachlor in breast adipose tissue and risk of female breast cancer.
Zheng T, Holford T, Tessari J, Mayne S, Zahm S, Owens P, Zhang B, Ward B, Carter D, Zhang Y, Zhang W, Dubrow R, Boyle P. Oxychlordane and trans-nonachlor in breast adipose tissue and risk of female breast cancer. Journal Of Cancer Epidemiology And Prevention 2000, 5: 153-60. PMID: 11051111.Peer-Reviewed Original ResearchConceptsAdipose tissue levelsBreast cancer riskFemale breast cancerBreast adipose tissueBreast cancerRisk factorsOdds ratioAdipose tissueBenign breast disease controlsFemale breast cancer riskPrimary breast cancer patientsCovariate-adjusted odds ratioEnvironmental exposuresProgesterone receptor statusBreast cancer patientsRecent epidemiological studiesMenopausal statusReceptor statusHighest quartileEpidemiological studiesCancerMajor metaboliteRiskStructured questionnaireOverall significant impact
1999
DDE and DDT in Breast Adipose Tissue and Risk of Female Breast Cancer
Zheng T, Holford T, Mayne S, Ward B, Carter D, Ownes P, Dubrow R, Zahm S, Boyle P, Archibeque S, Tessari J. DDE and DDT in Breast Adipose Tissue and Risk of Female Breast Cancer. American Journal Of Epidemiology 1999, 150: 453-458. PMID: 10472944, DOI: 10.1093/oxfordjournals.aje.a010033.Peer-Reviewed Original ResearchConceptsBreast cancer riskBreast adipose tissueTissue levelsCancer riskAdipose tissueBenign breast disease controlsIncident breast cancer casesYale-New Haven HospitalBreast-related surgeryAdipose tissue levelsFemale breast cancerCase-control studyBreast cancer casesMean tissue levelsLogistic regression modelsRank sum testHighest quartileSurgical specimenDichlorodiphenyltrichloroethane (DDT) exposureOdds ratioBreast cancerCancer casesDisease controlSum testMean levels
1997
Severe Obesity as an Explanatory Factor for the Black/White Difference in Stage at Diagnosis of Breast Cancer
Jones B, Kasl S, Curnen M, Owens P, Dubrow R. Severe Obesity as an Explanatory Factor for the Black/White Difference in Stage at Diagnosis of Breast Cancer. American Journal Of Epidemiology 1997, 146: 394-404. PMID: 9290499, DOI: 10.1093/oxfordjournals.aje.a009292.Peer-Reviewed Original ResearchConceptsSevere obesityBreast cancerWhite womenRacial differencesBlack womenTNM stage IIPrevalence of obesityLogistic regression modelsObserved racial differencesBlack/White DifferencesRetrospective studyOdds ratioHigh prevalenceObesityStage IICancerDiagnosisWomenWhite differencesPrevalenceRegression modelsDifferencesLater stagesDiseaseImportant roleBreast Cancer Risk Factors According to Combined Estrogen and Progesterone Receptor Status: A Case-Control Analysis
Yoo K, Tajima K, Miura S, Takeuchi T, Hirose K, Risch H, Dubrow R. Breast Cancer Risk Factors According to Combined Estrogen and Progesterone Receptor Status: A Case-Control Analysis. American Journal Of Epidemiology 1997, 146: 307-314. PMID: 9270409, DOI: 10.1093/oxfordjournals.aje.a009271.Peer-Reviewed Original ResearchConceptsProgesterone receptor statusHormone receptor statusReceptor statusEstrogen receptor statusRisk factorsBreast cancerAichi Cancer Center HospitalBreast cancer risk factorsDiagnosis/interviewReproductive risk factorsCancer Center HospitalCancer risk factorsGradient of riskBreast cancer casesCase-control analysisPolytomous logistic regressionCancer-free controlsCommon control groupStratification of casesJoint estrogenCenter HospitalMenstrual regularityCigarette smokingCombined EstrogenProgesterone receptor
1995
Can mammography screening explain the race difference in stage at diagnosis of breast cancer?
Jones B, Kasl S, Curnen M, Owens P, Dubrow R. Can mammography screening explain the race difference in stage at diagnosis of breast cancer? Cancer 1995, 75: 2103-2113. PMID: 7697601, DOI: 10.1002/1097-0142(19950415)75:8<2103::aid-cncr2820750813>3.0.co;2-2.Peer-Reviewed Original ResearchConceptsBreast cancerWhite womenMammography screeningLate-stage diagnosisPopulation-based dataDevelopment of symptomsLate-stage cancerBlack womenAfrican American womenRace differencesRace-specific analysesScreening historyObserved race differencesRetrospective studyMammographic screeningActive surveillanceConnecticut hospitalsStage cancerCancerDiagnosisSocioeconomic statusWomenStage diagnosisSignificant predictorsAmerican women
1993
A hospital-based case-control study of breast-cancer risk factors by estrogen and progesterone receptor status
Yoo K, Tajima K, Miura S, Yoshida M, Murai H, Kuroishi T, Lee Y, Risch H, Dubrow R. A hospital-based case-control study of breast-cancer risk factors by estrogen and progesterone receptor status. Cancer Causes & Control 1993, 4: 39-44. PMID: 8431529, DOI: 10.1007/bf00051712.Peer-Reviewed Original ResearchConceptsHospital-based case-control studyBreast cancer risk factorsProgesterone receptor statusCase-control studyEstrogen receptorRisk factorsBreast cancerPR statusReceptor statusPR-negative breast cancerER-negative breast cancerFull-term pregnancyPR-negative casesBreast cancer casesCancer-free controlsSignificant differencesER statusMenstrual regularityEtiologic distinctionsBorderline differenceNegative casesCancerStatusAgePercent